Novel nucleic acid and polypeptide molecules
CA 2436661 A1 · Owner: Bodine, Sue C. · Inventors: Glass, David J.; Bodine, Sue C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The presetn invention provides for nucleic acid sequences that encoude novel mamalian intracellular signaling polypeptides designated MURF1, MURF3, or MA-, 61. The invention also provies assay systems that may be used to detect and/or measure agents that bind the MURFI or MAFBXgene product. The present invention also provides for diagnostic and therapeutic mehtods based on the interacton between MURF1 or MAFBX and agenets that initiate signal transduction or inhibition of ubiqutination throgh binding to MURF1 or MA-61 inhibiting the , mRNA expression of MURF1 MURF3, or MA-61, or inhibiting the MURF1 MURF3, or , MAFBXpathway.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 30, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.